Paper Details

  1. Home
  2. Paper Details

[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].

Author: AlvarezLuís Gonzalo, BlairSilvia, RíosAlexandra, SanínFelipe, TobónAlberto, VásquezAna María

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study describes the implementation of an artesunate (AS)-mefloquine (MQ) treatment program for Plasmodium falciparum malaria in Antioquia, Colombia. The addition of primaquine (PQ) aimed to eliminate malaria gametocytes and reduce transmission.
Paper Details　
Original Abstract of the Article :
The treatment of Plasmodium falciparum malaria requires a safe and effective therapeutic treatment regimen, which in turn has high impact on the transmission. In 2006, an artesunate (AS)-mefloquine (MQ) treatment program was implemented in Antioquia. In addition, primaquine (PQ) was added to elimina...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/20128355

データ提供：米国国立医学図書館（NLM）

Combating Malaria Transmission: An Effective Treatment Regimen

This article investigates the effectiveness of a specific treatment regimen for Plasmodium falciparum malaria, focusing on its impact on disease transmission. The authors examine the use of artesunate-mefloquine-primaquine in treating malaria and assess its efficacy in eliminating gametocytes, which play a crucial role in disease transmission. The research aims to evaluate the effectiveness of this treatment regimen in reducing malaria transmission and improving patient outcomes. The article explores the effectiveness of an artesunate-mefloquine-primaquine regimen in treating malaria, highlighting its impact on reducing disease transmission.

The Importance of Gametocyte Elimination

The article emphasizes the crucial role of gametocyte elimination in malaria treatment. The use of primaquine in this regimen effectively eliminates gametocytes from the bloodstream, reducing the likelihood of disease transmission to other individuals. This finding highlights the importance of considering transmission dynamics when treating malaria and the benefits of using multidrug regimens that target both parasitic stages. The study provides valuable insights into the effectiveness of this treatment regimen in reducing malaria transmission.

Implications for Malaria Control and Prevention

The research highlights the importance of utilizing effective treatment regimens to combat malaria transmission. The use of artesunate-mefloquine-primaquine, which effectively eliminates gametocytes, plays a significant role in malaria control efforts. The study underscores the need for continued research and development of novel antimalarial therapies, particularly those targeting gametocytes, to effectively combat this devastating disease.

Dr.Camel's Conclusion

Just like a camel navigating a scorching desert, individuals battling malaria need effective treatments to survive and prevent further spread. This study highlights the importance of a multidrug regimen that targets both parasitic stages, offering hope for better malaria control and a healthier future.

Date :
  1. Date Completed 2010-04-26
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

20128355

DOI: Digital Object Identifier

S0120-41572009000200015

Related Literature

Article Analysis
・Effects of primaquine
SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.